Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Net Margin: 2009-2020

Historic Net Margin for Avadel Pharmaceuticals (AVDL) over the last 11 years, with Dec 2020 value amounting to 70.34%.

  • Avadel Pharmaceuticals' Net Margin rose 48455.00% to 70.34% in Q4 2020 from the same period last year, while for Dec 2020 it was 134.91%, marking a year-over-year increase of 26330.00%. This contributed to the annual value of -28.30% for FY2020, which is 10010.00% up from last year.
  • According to the latest figures from Q4 2020, Avadel Pharmaceuticals' Net Margin is 70.34%, which was down 80.41% from 359.10% recorded in Q3 2020.
  • Avadel Pharmaceuticals' Net Margin's 5-year high stood at 452.64% during Q2 2020, with a 5-year trough of -414.21% in Q4 2019.
  • Moreover, its 3-year median value for Net Margin was -55.66% (2019), whereas its average is -20.06%.
  • Per our database at Business Quant, Avadel Pharmaceuticals' Net Margin slumped by 1,150,973bps in 2016 and then surged by 50,166bps in 2020.
  • Avadel Pharmaceuticals' Net Margin (Quarterly) stood at 10.99% in 2016, then plummeted by 3,471bps to -23.73% in 2017, then plummeted by 28,153bps to -305.25% in 2018, then tumbled by 10,895bps to -414.21% in 2019, then soared by 48,455bps to 70.34% in 2020.
  • Its Net Margin stands at 70.34% for Q4 2020, versus 359.10% for Q3 2020 and 452.64% for Q2 2020.